← Open Payments lookup

RICHARD KIRKPATRICK: Open Payments

NPI 1851377030 · LONGVIEW, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,910 in 136 payments from 40 companies in 2025. Trend: 2023 $2,517 · 2024 $2,876 · 2025 $2,910

Food & beverage: $2,860Long term medical supply or device loan: $50
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP25$560
Novartis Pharmaceuticals Corporation9$247
Salix Pharmaceuticals, a division of Bausch Health US, LLC14$188
Corcept Therapeutics7$151
PFIZER INC.5$109
Lundbeck LLC5$107
Axsome Therapeutics, Inc.3$99
Lilly USA, LLC5$99
Otsuka America Pharmaceutical, Inc.4$86
Abbott Laboratories3$84

Products named: LEQVIO, AIRSUPRA, REXULTI, BREZTRI, XIFAXAN, Korlym, Auvelity, Kerendia.

Industry payments across WA — which companies pay providers there.